Astrana Health, Inc. (ASTH) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
69/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 8 wins, 4 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q23/3 |
WinASTH / S&P 89.27% / 15.20% |
WinASTH / S&P 58.91% / 15.00% |
WinASTH / S&P 59.62% / 50.40% |
| 2026-Q12/3 |
WinASTH / S&P -1.17% / -4.33% |
WinASTH / S&P 56.69% / 11.30% |
LoseASTH / S&P -15.07% / 27.70% |
| 2025-Q41/3 |
LoseASTH / S&P -12.49% / 2.65% |
WinASTH / S&P 56.39% / 9.00% |
LoseASTH / S&P -47.78% / 13.40% |
| 2025-Q32/3 |
WinASTH / S&P 13.95% / 8.12% |
WinASTH / S&P 68.17% / 4.61% |
LoseASTH / S&P -84.62% / 13.45% |
| 2025-Q21/3 |
LoseASTH / S&P -19.77% / 10.94% |
WinASTH / S&P 51.97% / 4.83% |
LoseASTH / S&P -63.89% / 10.63% |
| 2025-Q12/3 |
WinASTH / S&P -1.65% / -4.27% |
WinASTH / S&P 54.81% / 4.98% |
LoseASTH / S&P -44.70% / 10.57% |
| 2024-Q41/3 |
LoseASTH / S&P -45.58% / 2.41% |
WinASTH / S&P 46.72% / 5.25% |
LoseASTH / S&P -30.23% / 6.15% |
| 2024-Q33/3 |
WinASTH / S&P 42.85% / 5.89% |
WinASTH / S&P 29.71% / 5.89% |
WinASTH / S&P 35.42% / 6.11% |
| 2024-Q22/3 |
LoseASTH / S&P -3.41% / 4.28% |
WinASTH / S&P 22.76% / 5.38% |
WinASTH / S&P 45.45% / 5.12% |
| 2024-Q12/3 |
LoseASTH / S&P 9.63% / 10.56% |
WinASTH / S&P 19.34% / 5.71% |
WinASTH / S&P 36.08% / 5.59% |
| 2023-Q43/3 |
WinASTH / S&P 24.15% / 11.69% |
WinASTH / S&P 21.19% / 6.81% |
WinASTH / S&P 29.00% / 7.78% |
| 2023-Q32/3 |
WinASTH / S&P -2.37% / -3.27% |
WinASTH / S&P 27.06% / 7.52% |
LoseASTH / S&P -23.81% / -5.03% |
| 2023-Q21/3 |
LoseASTH / S&P -13.35% / 8.74% |
WinASTH / S&P 35.75% / 9.50% |
LoseASTH / S&P -34.00% / -8.57% |
| 2023-Q12/3 |
WinASTH / S&P 23.25% / 7.50% |
WinASTH / S&P 41.46% / 10.77% |
LoseASTH / S&P -36.18% / -15.69% |
| 2022-Q41/3 |
LoseASTH / S&P -24.13% / 7.56% |
WinASTH / S&P 47.84% / 11.88% |
LoseASTH / S&P -33.77% / -17.99% |
| 2022-Q32/3 |
WinASTH / S&P 1.06% / -4.88% |
WinASTH / S&P 38.31% / 13.47% |
LoseASTH / S&P -20.25% / -1.41% |
| 2022-Q22/3 |
LoseASTH / S&P -20.38% / -16.10% |
WinASTH / S&P 34.80% / 13.71% |
WinASTH / S&P 16.28% / 11.04% |
| 2022-Q11/3 |
LoseASTH / S&P -34.04% / -4.60% |
WinASTH / S&P 23.35% / 15.97% |
LoseASTH / S&P 26.67% / 42.23% |
| 2021-Q40/3 |
LoseASTH / S&P -19.30% / 11.03% |
LoseASTH / S&P 12.62% / 15.00% |
LoseASTH / S&P 49.50% / 96.40% |
| 2021-Q31/3 |
WinASTH / S&P 44.96% / 0.58% |
LoseASTH / S&P 9.64% / 10.77% |
LoseASTH / S&P 68.09% / 69.42% |
| 2021-Q22/3 |
WinASTH / S&P 131.86% / 8.55% |
LoseASTH / S&P 6.54% / 6.58% |
WinASTH / S&P 118.64% / 51.81% |
| 2021-Q13/3 |
WinASTH / S&P 48.28% / 6.17% |
WinASTH / S&P 10.82% / -1.06% |
WinASTH / S&P 144.90% / 7.39% |
| 2020-Q42/3 |
LoseASTH / S&P 1.84% / 12.15% |
WinASTH / S&P 22.58% / -3.72% |
WinASTH / S&P 165.79% / -33.42% |
| 2020-Q32/3 |
LoseASTH / S&P 8.73% / 8.93% |
WinASTH / S&P 41.09% / -2.04% |
WinASTH / S&P 754.55% / -27.10% |
| 2020-Q23/3 |
WinASTH / S&P 27.71% / 20.54% |
WinASTH / S&P 33.25% / -0.46% |
WinASTH / S&P 136.00% / -27.11% |
| 2020-Q12/3 |
LoseASTH / S&P -29.82% / -19.60% |
WinASTH / S&P 28.11% / 3.47% |
WinASTH / S&P 113.04% / -14.75% |
| 2019-Q42/3 |
LoseASTH / S&P 4.48% / 9.07% |
WinASTH / S&P 7.78% / 5.36% |
WinASTH / S&P 31.03% / 2.99% |
| 2019-Q31/3 |
WinASTH / S&P 5.45% / 1.70% |
LoseASTH / S&P -3.49% / 5.02% |
LoseASTH / S&P -87.06% / 0.21% |
| 2019-Q21/3 |
LoseASTH / S&P -8.79% / 4.30% |
WinASTH / S&P 14.34% / 6.64% |
LoseASTH / S&P -69.14% / 8.65% |
| 2019-Q11/3 |
LoseASTH / S&P -7.71% / 13.65% |
WinASTH / S&P 24.43% / 8.12% |
LoseASTH / S&P -71.60% / 14.29% |
| 2018-Q42/3 |
WinASTH / S&P -10.06% / -13.52% |
WinASTH / S&P 45.96% / 9.05% |
LoseASTH / S&P -67.78% / 18.23% |
| 2018-Q31/3 |
LoseASTH / S&P -14.66% / 7.71% |
WinASTH / S&P 81.11% / 10.21% |
LoseASTH / S&P ASTH unavailable / 19.06% |
| 2018-Q22/3 |
WinASTH / S&P 62.13% / 3.43% |
WinASTH / S&P 121.66% / 9.03% |
LoseASTH / S&P ASTH unavailable / 14.46% |
| 2018-Q11/3 |
LoseASTH / S&P -33.54% / -0.76% |
WinASTH / S&P 208.73% / 7.68% |
LoseASTH / S&P ASTH unavailable / 12.46% |
| 2017-Q42/3 |
WinASTH / S&P 146.15% / 6.64% |
WinASTH / S&P 554.05% / 7.03% |
LoseASTH / S&P ASTH unavailable / 13.82% |
| 2017-Q31/3 |
LoseASTH / S&P -2.50% / 4.48% |
WinASTH / S&P 464.91% / 5.68% |
LoseASTH / S&P ASTH unavailable / 17.57% |
| 2017-Q22/3 |
WinASTH / S&P 11.11% / 3.09% |
WinASTH / S&P 326.14% / 4.83% |
LoseASTH / S&P ASTH unavailable / 17.74% |
| 2017-Q12/3 |
WinASTH / S&P 20.00% / 6.07% |
WinASTH / S&P 190.60% / 3.67% |
LoseASTH / S&P ASTH unavailable / 13.32% |
| 2016-Q42/3 |
WinASTH / S&P 66.67% / 3.82% |
WinASTH / S&P 30.28% / 2.09% |
LoseASTH / S&P ASTH unavailable / 7.05% |
| 2016-Q31/3 |
LoseASTH / S&P -10.00% / 3.85% |
WinASTH / S&P 27.49% / 0.20% |
LoseASTH / S&P ASTH unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ASTH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 20.18% | 20.78% |
| Annualized return | 20.18% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ASTH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -50.03% | 83.14% |
| Annualized return | -12.95% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ASTH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 708.63% | 319.30% |
| Annualized return | 23.25% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |
| TSS, Inc. (TSSI) | United States | $0.288B | 24.06 |
| Information Services Group Inc. (III) | United States | $0.256B | 16.97 |
| HACKETT GROUP, INC. (HCKT) | United States | $0.254B |